Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Shuttle Pharmaceuticals Holdings Inc SHPH

Healthcare Drug Manufacturers - Specialty & Generic
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:SHPH)

Shuttle Pharmaceuticals and United Dogecoin Announce Purchase Order for up to 3,000 ElphaPex Dogecoin and Litecoin Mining Rigs

Newsfile 5 days ago

United Dogecoin Goes Public in Landmark Merger, Powering a Scaled, Next Generation DOGE Mining Operation

Newsfile May 1, 2026

Shuttle Merges with United Dogecoin to Become the World's Largest Public Dogecoin Miner

Newsfile April 30, 2026

RETRANSMISSION: Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows

Newsfile March 27, 2026

Shuttle Pharmaceuticals Launches Autonomous Self Reasoning AI Agent for Scientific Workflows

Newsfile March 26, 2026

Shuttle Pharmaceuticals Announces $3.5 Million Public Offering

Newsfile March 6, 2026

Utah Approves AI Prescriptions Drugs. How AI Is Saving Time, Cutting Costs - and Why Molecule.ai's Drug Discovery Platform Matters More Than Ever

Newsfile January 13, 2026

Shuttle Pharmaceuticals Acquires AI Health Platform

Newsfile November 21, 2025

Shuttle Pharmaceuticals Announces Above-the-Market $2.5 Million Private Placement at Effective Price per Share of $4.00

Newsfile November 3, 2025
View More News ››

Opinion & Analysis (NDAQ:SHPH)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:SHPH)

Buy buddy buy.

Otherwise it will be FOMO time for you fellas out there anyway,so good luck to all of you
coolfooldumbguy - November 21, 2025

Shuttle Pharma Provides Corporate Update and Reports 2024

Shuttle Pharma’s recent highlights include the following: Accelerated patient enrollment of the Company’s key Phase 2 clinical...
AveragePenny - February 28, 2025

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH): A Disc

https://beyondspx.com/article/shuttle-pharmaceuticals-holdings-inc-nasdaqshph-a-discovery-stage-pharma-innovating-radiation-therapyLLM...
MikeTester - January 23, 2025

Shuttle Pharma Reaches Milestone in Patient Enrollment...

GAITHERSBURG, Md., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a...
AveragePenny - January 22, 2025

GROUNDBREAKING CANCER TREATMENT A CONSIDERATION FOR FAMILY..

Strong Data from NIH Sponsored Clinical Trial Suggests Ropidoxuridine Could be Major Advancement for Cancer Patients and Big Win for...
AveragePenny - December 16, 2024

Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinic

GAITHERSBURG, Md., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a...
AveragePenny - November 27, 2024
View more Bullboard ››

Mobix Labs Inc

Mobix Labs Inc

Mobix Labs, Inc. designs, develops, and sells components and systems for advanced wireless and wired connectivity, radio ...
View More »

Podcasts